Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acetylsalicylic Acid as Secondary Prevention in Colorectal Cancer

NCT03326791 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT03326791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03326791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acetylsalicylic Acid as Secondary Prevention in Colorectal Cancer
Lead sponsor
Oslo University Hospital
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
December 15, 2017
Completion date
June 30, 2026
Enrollment
466 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, colorectal cancer liver metastases, liver metastases